Literature DB >> 16951319

The extracellular membrane-proximal domain of human membrane IgE controls apoptotic signaling of the B cell receptor in the mature B cell line A20.

Monica Poggianella1, Marco Bestagno, Oscar R Burrone.   

Abstract

Ag engagement of BCR in mature B cells can deliver specific signals, which decide cell survival or cell death. Circulating membrane IgE+ (mIgE+) cells are found in extremely low numbers. We hypothesized that engagement of an epsilonBCR in a mature isotype-switched B cell could induce apoptosis. We studied the role of the extracellular membrane-proximal domain (EMPD) of human mIgE upon BCR engagement with anti-Id Abs. Using mutants lacking the EMPD, we show that this domain is involved in controlling Ca2+ mobilization in immunoreceptors of both gamma and epsilon isotypes, as well as apoptosis in signaling originated only from the epsilonBCR. We mapped to the epsilonCH4 ectodomain the region responsible for apoptosis in EMPD-deleted receptors. Ca2+ mobilization was not related to apoptotic signaling. This apoptotic pathway was caspase independent, involved ERK1/2 phosphorylation and was partially rescued by CD40 costimulation. We therefore conclude that the EMPD of human mIgE is a key control element of apoptotic signaling delivered through engagement of epsilonBCR within the context of a mature B cell.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16951319     DOI: 10.4049/jimmunol.177.6.3597

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  IgH isotype-specific B cell receptor expression influences B cell fate.

Authors:  Pei Tong; Alessandra Granato; Teng Zuo; Neha Chaudhary; Adam Zuiani; Seung Seok Han; Rakesh Donthula; Akritee Shrestha; Debattama Sen; Jennifer M Magee; Michael P Gallagher; Cees E van der Poel; Michael C Carroll; Duane R Wesemann
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

2.  Targeting the extracellular membrane-proximal domain of membrane-bound IgE by passive immunization blocks IgE synthesis in vivo.

Authors:  Stefan Feichtner; Daniela Inführ; Gertrude Achatz-Straussberger; Doris Schmid; Alexander Karnowski; Marinus Lamers; Claudio Rhyner; Reto Crameri; Gernot Achatz
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

Review 3.  AID-induced remodeling of immunoglobulin genes and B cell fate.

Authors:  Brice Laffleur; Nicolas Denis-Lagache; Sophie Péron; Christophe Sirac; Jeanne Moreau; Michel Cogné
Journal:  Oncotarget       Date:  2014-03-15

Review 4.  B Cell Intrinsic Mechanisms Constraining IgE Memory.

Authors:  Brice Laffleur; Orianne Debeaupuis; Zeinab Dalloul; Michel Cogné
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

5.  Specificity and biologic activities of novel anti-membrane IgM antibodies.

Authors:  Rachel S Welt; Jonathan A Welt; David Kostyal; Yamuna D Gangadharan; Virginia Raymond; Sydney Welt
Journal:  Oncotarget       Date:  2016-11-15

6.  Regulation of B cell fate by chronic activity of the IgE B cell receptor.

Authors:  Zhiyong Yang; Marcus J Robinson; Xiangjun Chen; Geoffrey A Smith; Jack Taunton; Wanli Liu; Christopher D C Allen
Journal:  Elife       Date:  2016-12-09       Impact factor: 8.140

Review 7.  Non-classical B Cell Memory of Allergic IgE Responses.

Authors:  Sean P Saunders; Erica G M Ma; Carlos J Aranda; Maria A Curotto de Lafaille
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

8.  Structural Model of the mIgM B-Cell Receptor Transmembrane Domain From Self-Association Molecular Dynamics Simulations.

Authors:  Mario D Friess; Kristyna Pluhackova; Rainer A Böckmann
Journal:  Front Immunol       Date:  2018-12-17       Impact factor: 7.561

9.  Ontogeny of human IgE-expressing B cells and plasma cells.

Authors:  F Ramadani; H Bowen; N Upton; P S Hobson; Y-C Chan; J-B Chen; T W Chang; J M McDonnell; B J Sutton; D J Fear; H J Gould
Journal:  Allergy       Date:  2016-06-08       Impact factor: 13.146

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.